Niagara Falls, NY – February 17, 2022 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a nuclear medicine PET imaging device systems and clinical services company, is pleased to announce today that the Company has retained Medical Device Academy ”MDA”) as its consultant for the... Read More
January 31, 2022
Re: Shareholder Update
Dear Positron Shareholders,
In consideration of our announcement of the collaboration with Neusoft Medical Systems and the expansion into the PET/CT modality we are pleased to update you on key developments that set the path for the growth and success at Positron for... Read More
Positron Enters Long Term Cooperation Agreement with Neusoft Medical Systems for the Development and Distribution of Positron’s State of the Art PET/CT System in North America
Niagara Falls, NY – January 18, 2022 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a nuclear medicine... Read More
Positron Files all Financial Reports and Announces the Company is Current with its OTC Reporting & Disclosures
Niagara Falls, NY – October 29, 2021 (GLOBE NEWSWIRE) -- Positron Corp (“Positron” or the “Company”) (OTC: POSC), a nuclear medicine PET imaging company specializing in the field of cardiac Positron... Read More
Positron Announces Timeline for Becoming Current with its OTC Reporting & Disclosures
Niagara Falls, NY – September 14, 2021 (GLOBE NEWSWIRE) -- Positron Corp (“Positron” or the “Company”) (OTC: POSC) is pleased to announce that Positron has received full OTCIQ access for its filing and approval process with OTC... Read More
Positron Retains Healthcare Advisor I-Square Ventures to Implement Strategy and Expand Market Share
Niagara Falls, NY – July 15, 2021 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC) is pleased to announce today that it has retained the services of I- Square Ventures (“I-Square”)... Read More